WRIGHT
MEDICAL GROUP, INC.
Restricted Stock Grant Agreement
Non-Employee Director
Award
Granted to (“Grantee”):
Grant Date:
Number of Shares (“Shares”):
THIS
RESTRICTED STOCK GRANT AGREEMENT (the “Agreement”) is
made as of the Grant Date by and between Wright Medical Group,
Inc., a Delaware corporation with its principal place of business
at 5677 Airline Road, Arlington, Tennessee 38002 (the
“Company”) and Grantee pursuant to the Wright Medical
Group, Inc. 2009 Equity Incentive Plan, as amended from time to
time (the “Plan”) and which is hereby incorporated by
reference.
WHEREAS,
Grantee is associated with the Company or its affiliate as a
non-employee director; and
WHEREAS,
the Compensation Committee of the Company’s Board of
Directors (the “Committee”) has authorized that Grantee
be granted shares of the Company’s Common Stock
(“Stock”) subject to the restrictions stated
below;
NOW,
THEREFORE, the parties agree as follows:
|
1.
|
|
Grant of Stock
. Subject to the terms
and conditions of this Agreement and of the Plan, the Company
hereby grants to Grantee the Shares.
|
|
|
|
|
|
2.
|
|
Vesting Schedule
. The interest of
Grantee in the Shares shall vest as to one-fourth (
1
/ 4 ) of the Shares on the first
anniversary of the Grant Date, and as to an additional one-fourth
( 1 / 4 ) on each succeeding anniversary
date, so as to be 100% vested on the fourth anniversary thereof,
conditioned upon Grantee maintaining status as an Eligible Person
(as defined in the Plan) as of each vesting date. Notwithstanding
the foregoing, the interest of Grantee in the Shares shall vest as
to:
|
|
|
2.1.
|
|
100% of the then unvested Shares
upon a Change of Control. For purposes of this Agreement a
“Change of Control” shall mean the first to occur on or
after the Grant Date of any of the following:
|
(a) The
acquisition by any individual, entity or group (within the meaning
of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of
1934, as amended (the “Exchange Act”)) (a
“Person”) of beneficial ownership (within the meaning
of Rule 13d-3 promulgated under the Exchange Act) of 50% or
more (on a fully diluted basis) of either (A) the then
outstanding shares of Stock, taking into account as outstanding for
this purpose such Stock issuable upon the exercise of options or
warrants, the conversion of convertible stock or debt, and the
exercise of any similar right to acquire such Stock (the
“Outstanding Company Common Stock”) or (B) the
combined voting power of the then outstanding voting securities of
the Company entitled to vote generally in the election of directors
(the “Outstanding Company Voting Securities”);
provided, however, that for purposes of this subsection (a), the
following acquisitions shall not constitute a Change of Control:
(x) any acquisition by the Company or any
“affiliate” of the Company, within the meaning of 17
C.F.R. § 230.405 (an “Affiliate”), (y) any
acquisition by any employee benefit plan (or related trust)
sponsored or maintained by the Company or any Affiliate,
(z) any acquisition by any corporation or business entity
pursuant to a transaction which complies with clauses (A) and
(B) of subsection (a) of this Section 2.1 (persons and
entities described in clauses (x), (y), and (z) being referred
to herein as “Permitted Holders”);
Restricted
Stock Grant Agreement
Page 2
(b) The
consummation of a reorganization, merger or consolidation or sale
or other disposition of all or substantially all of the assets of
the Company (a “Business Combination”), in each case,
unless, following such Business Combination, (A) all or
substantially all of the individuals and entities who were the
beneficial owners, respectively, of the Outstanding Company Common
Stock and Outstanding Company Voting Securities immediately prior
to such Business Combination beneficially own, directly or
indirectly, more than 60% of, respectively, the then outstanding
shares of common stock and the combined voting power of the then
outstanding voting securities entitled to vote generally in the
election of directors, as the case may be, of the corporation
resulting from such Business Combination (including, without
limitation, a corporation which as a result of such transaction
owns the Company or all or substantially all of the Company’s
assets either directly or through one or more subsidiaries) in
substantially the same proportions as their ownership, immediately
prior to such Business Combination, of the Outstanding Company
Common Stock and Outstanding Company Voting Securities, as the case
may be, (B) no Person (excluding any Permitted Holder)
beneficially owns, directly or indirectly, 50% or more (on a fully
diluted basis) of, respectively, the then outstanding shares of
common stock of the corporation resulting from such Business
Combination, taking into account as outstanding for this purpose
such common stock issuable upon the exercise of options or
warrants, the conversion of convertible stock or debt, and the
exercise of any similar right to acquire such common stock, or the
combined voting power of the then outstanding voting securities of
such corporation except to the extent that such ownership existed
prior to the Business Combination, and (C) at least a majority
of the members of the board of directors of the corporation
resulting from such Business Combination were members of the
incumbent Board at the time of the execution of the initial
agreement providing for such Business Combination;
(c) The
approval by the stockholders of the Company of a complete
liquidation or dissolution of the Company;
(d) The
sale of at least 80% of the assets of the Company to an unrelated
party, or completion of a transaction having a similar effect;
or
(e) The
individuals who on the date of this Agreement constitute the Board
of Directors thereafter cease to constitute at least a majority
thereof; provided that any person becoming a member of the Board of
Directors subsequent to the date of this Agreement and whose
election or nomination was approved by a vote of at least
two-thirds of the directors who then comprised the Board of
Directors immediately prior to such vote shall be considered a
member of the Board of Directors on the date of this
Agreement.
|
|
2.2.
|
|
100% of the unvested Shares upon
Grantee’s death.
|
|
|
3.1.
|
|
The
Shares granted hereunder may not be sold, pledg
|
|